Genomate Health

Our work is deeply personal. We’re committed to changing the landscape of cancer care by harnessing AI and precision medicine to give every patient the best possible chance. In the latest Cancer Patient Lab session, our founder, Istvan Petak, MD, PhD, shares his journey and passion for precision oncology. He dives into the real challenges of matching patients with the right therapies based on their unique genetic profiles and how Genomate® is making this a reality. In this recording, you’ll discover: ✅ Why comprehensive molecular testing is vital for making informed treatment decisions. ✅ How our technology is helping clinicians tailor treatments to each patient, leading to better outcomes. ✅ Real-world examples of how we’re making a difference in the lives of cancer patients. Learn more about how we’re working to bring hope and better outcomes to those fighting cancer. Notes and video recording below 👇 #Genomate #CancerPatientLab #PrecisionOncology #PersonalizedMedicine 

In a journey spanning three decades, our founder, Istvan Petak, MD, PhD, has remained steadfast in his mission to personalize cancer treatment. Watch this powerful video where Dr. Petak shares his unwavering commitment to precision oncology—matching the right targeted therapy to each cancer patient based on their unique molecular profile. Join us as we bring this dream closer to reality. Together, we can transform cancer care. Watch the full interview here: https://lnkd.in/dadYrhWx #OncoDaily #PrecisionOncology #GenomateHealth

As a CancerX Moonshot founding member, we collaborate with other leaders in the oncology and digital health space to set priorities and practices that will help us harness the full power of innovation to achieve the goals of The White House Cancer Moonshot initiative 🚀 Today, we want to take a moment and thank the amazing organizations making it happen: Moffitt Cancer Center, Digital Medicine Society (DiMe), the Office for the National Coordinator for Health Information Technology (ONC), Office of the Assistant Secretary for Health (OASH)) and all the other 200+ members fighting cancer 👏 1104Health AARDEX Group - Medication Adherence Tools Amazon Web Services (AWS) American Cancer Society AstraZeneca Athelo Health Atrium Health Autonomize AI Biofourmis Biohacking Village Blue Spark Technologies Blue Note Therapeutics Bulldog Medical C the Signs Canadian Cancer Society Cancer Support Community Carium City of Hope Clario Current Health Dana-Farber Cancer Institute Datavant Elevance Health Empatica Emerson Collective Family Reach Flatiron Health Foley & Lardner LLP Genentech Graphite Health Gray Oncology Solutions Haystack Health Health Chain Health Wallet HIKE HEALTH® ...continued in the comments

To evaluate the performance of the Genomate® Digital Drug-Assignment (DDA) system, we first processed tumor molecular profiles from SHIVA01, generating individual scores for the drugs received by each patient based on the tumor molecular profile. Overall, 56% of patients responded to personalized therapy, which was a promising result but not better than chemotherapy used in the other arm of the trial. Our results demonstrated that patients treated with therapies supported by Genomate® achieved a 69% benefit rate, better than chemotherapy, while therapies that were indicated to fail achieved only a 17% response rate. Similarly, the mPFS was significantly longer in patients treated with therapies supported by Genomate® than in the patient group indicated to fail. These results demonstrated the clinical predictivity of Genomate®. They indicated improved decision by processing the full tumor molecular profiles provided by clinically used NGS tests, instead of searching for “actionable” alterations. Source: Petak, I., Kamal, M., Dirner, A. et al. A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial. Nature Partner Journal NPJ Precision Oncology 5, 59 (2021) https://lnkd.in/e4gG5sR 

We believe it's time for AI and computational reasoning to empower oncologists in making precise treatment decisions. With an expanding range of treatments, understanding cancer biology and leveraging vast biomedical data is crucial. Discover how technology is transforming cancer care in OncoDaily Dialogue #9 with Istvan Petak, MD, PhD and Roupen Odabashian MD, FRCPC, ABIM. Watch the full interview here: https://lnkd.in/dadYrhWx #OncoDaily #PrecisionOncology #GenomateHealth

Today, on #WorldLungCancerDay, we unite to raise awareness and support the millions affected by lung cancer. With an estimated 234,580 new cases and 125,070 deaths in the US alone in 2024, the fight against lung cancer is more critical than ever. At Genomate Health, our mission is deeply personal. We are dedicated to transforming lung cancer treatment through AI-powered personalized medicine. By creating tailored treatment plans based on each patient's unique genetic profile, we aim to improve outcomes and offer hope. And we mean it! Our #ASCO2024 findings have shown that Genomate® can extend overall survival by 2.6 times and progression-free survival by 3 times for lung cancer patients. Join us in the fight against lung cancer. Together, we can make a difference. #LungCancerAwareness #PrecisionOncology #GenomateHealth

Hello, Amazing Birmingham, UK, and Amazing Plug and Play. I am excited to introduce Genomate Health to one of the most significant innovation ecosystems in the world (500+ corporate partners, 250+ investments per year, 60+ offices worldwide, breeding 32 unicorns). Thank you, Plug and Play Tech Center, Plug and Play Health, and Plug and Play UK, for accepting us in your community and connecting us to leading Pharmaceutical, MedTech, and IT technology corporations and investors in the field with whom we can work together to bring our solution that enables oncologists to fully implement precision oncology for their cancer patients as fast as possible. We started our journey by focusing on healthcare providers; now, we also want to open up to corporate partners by delivering value and solutions for their needs, accelerating the clinical development of new therapies, and teaming up to solve the most challenging problems in healthcare. I congratulate all the other health tech startups selected to PnP with us: https://lnkd.in/dBe5mWq3 Thank you, Adam McGuinness and team, Miruna Chipara, Agata Maria Bendik, and Polina S., for organizing yesterday's fantastic kickoff workshop.   Thank you, Kieran Borrett, Plug and Play UK.   Thank you, the University of Birmingham and West Midlands Health Tech Innovation Accelerator - WMHTIA, for hosting us. Thank you, STARTUP CREASPHERE powered by Plug and Play and Liam Grover, FMedSci, FIMMM

We are thrilled to announce that Genomate Health has been selected to join the prestigious Plug and Play UK Health Accelerator Program as part of their second cohort. We are honored to be part of this journey and can't wait to collaborate with industry experts, leading universities, and fellow innovators around the world to generate better patient outcomes. Stay tuned for updates! #GenomateHealth #PrecisionOncology #PNPUK #WMIA

Friendships are the bonds that enrich our lives, providing support, compassion, and strength, especially in challenging times. In the world of cancer treatment, friendships are not just about personal connections—they play a crucial role in diagnosis, treatment, advocacy, recovery, and beyond. To all our friends—patients, healthcare professionals, supporters, and colleagues—thank you for being a part of our journey. Together, we are transforming cancer treatment and making a real difference in the lives of many. Happy #InternationalFriendshipDay! 💚

💰 Are you interested in creating a #digitalstrategy to improve #equity and reduce patient costs? 📕 If so, check out our Solutions Catalog. It features 33 fit-for-purpose tools available on the market that you can pull off the shelf and use to implement your digital strategy. And don’t forget to reference the companion Core Competencies Guide (https://bit.ly/47456Sg) to walk you through the entire process of successfully designing and implementing your plan! 👏 Thank you to these leading organizations for contributing their solutions to our Solutions Catalog: Biofourmis, Blue Spark Technologies, Bulldog Medical, Cancer Support Community, CancerIQ, Cedar, CureMatch, Inc., Deep Bio Inc., Flatiron Health, Folia Health: The Home-Reported Outcomes Company, Galleri Test, Genomate Health, Jasper Health, The Leukemia & Lymphoma Society, Lunit Oncology, Massive Bio, Medable, Inc, MedHaul, Navya Care, NOUL Co., Ltd., OncoPower, Osara Health, Outcomes4Me, Power, Reimagine Care, Science 37, Sidekick, SOPHiA GENETICS, Spesana, TailorMed, Tempus AI, Thyme Care, Volpara Health 🔗 https://bit.ly/3QuN8Bo